" class="no-js "lang="en-US"> NuvoAir - Medtech Alert
Thursday, September 21, 2023
NuvoAir | Pharmtech Focus


About NuvoAir


NuvoAir offers a care platform designed to support people with respiratory conditions achieve better outcomes, providers make the right clinical decisions and health plans achieve higher ROI.

Related Story

Science 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical Trials

September 8 2022

Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced a […]

NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment

May 26 2022

NuvoAir’s Asthma Assessment Service uses respiratory physiologists and connected, award-winning home monitoring technology, such as […]

NuvoAir Series A Funding Reaches $25M to Expand Patient-Centric Care and Clinical Trials Platform

January 20 2022

NuvoAir, a leading digital healthcare company working in chronic disease management, raised $11M in a […]

NuvoAir Respiratory Platform Shows Promise for Long-Term Remote Monitoring of Asthma

August 27 2021

Three new studies show how home monitoring technology – developed by leading digital health company NuvoAir – […]

NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions

June 23 2021

NuvoAir – the digital health company on a mission to improve the lives of millions […]